Report Description
The global egg allergy market is anticipated to expand at substantial CAGR during the forecast period, between 2021 and 2028. Egg allergy refers to an immune hypersensitivity to proteins, found in chicken eggs. When the immune system becomes overly sensitive to proteins in egg whites/yolks, an allergy develops. When eggs are swallowed, the body produces chemicals to fight them because they are perceived as a foreign intruder. These chemicals cause the symptoms of an allergic reactions. The symptoms to egg allergies include stomach cramps, vomiting, repetitive cough, tightness in the throat, and shortness of breath. The egg allergy market constitutes various key players in the medical field that launch treatment and diagnosis measures to cure the allergy, which is prevalent in both children and adults.

Market Trends, Drivers, Restraints, and Opportunities:
- Rising prevalence of egg allergies due to increasing consumption of protein eggs has driven the demand for egg allergy medications in the market.
- Improved allergy diagnosis and efficiency in the quality of medical services provided has significantly boosted the market.
- Lack of awareness about new and improved medications and healthcare has restricted the market in developing countries.
- High cost of medications and treatment are unaffordable by some people which prevents the widespread emergence of the market.
- Growth of health infrastructure and development of various treatments and medicines to cure allergies is expected to fuel the market.
Scope of the report:
The report on the global egg allergy market includes an assessment of the market, size, share, trends, segments, and regional markets. Overview and dynamics have been included in the report.
Attributes | Details |
Report Title | Egg Allergy Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
Base Year | 2020 |
Historic Data | 2018 & 2019 |
Forecast Period | 2021–2028 |
Segmentation | Age Groups (Children and Adults), Diagnosis (Skin Test, Blood Test, Food Challenge, and Others), Treatments (Medication and Oral Immunotherapy), End-users (Hospitals & Clinics, Diagnostic Centres, Research Institutes, and Others) |
Regional Scope | Asia Pacific, North America, Europe, Latin America, and Middle East & Africa |
Report Coverage | Market scope, analysis, share, competitive analysis, growth facts, restraints, opportunities, and revenue forecast |
Key Players Covered | Genentech Inc.; Novartis AG.; Pfizer Inc.; Sun Pharmaceutical Industries Ltd.; Bayer AG; Abbott; Astellas Pharma Inc.; Sanofi; Merck & Co. Inc.; and Creative Diagnostic Medicare Pvt. Ltd. |
Egg Allergy Market Segment Insights:
The children segment is projected to grow significantly during the forecast period
Based on age groups, the egg allergy market can be bifurcated into children and adults. The children segment is projected to grow significantly during the forecast period. Studies show that 70% of children with egg allergies outgrow the condition by the age of 5, with the right treatment and diagnosis. The symptoms for egg allergies in children can range from a mild rash to anaphylaxis. Egg allergies among adults is a rare condition but can be treated with medications or the adult can eat products that are substitutes to eggs.
The skin test segment is projected to hold significant market share
Based on diagnosis, the market can be segmented into skin test, blood test, food challenge and others. The skin test segment is projected to hold significant market share. A skin test is an observational test that allows the doctor to see if the person has had any skin reaction due to the consumption of egg within the first 15 minutes. A blood test measures the body’s immune system’s response to eggs while checking the number of antibodies in the bloodstream that detects an allergic reaction.

The oral immunotherapy segment is projected to expand at a high CAGR
Based on treatments, the market can be divided into oral immunotherapy and medication. The oral immunotherapy segment is projected to expand at a high CAGR. Oral immunotherapy desensitizes people to egg allergens. This is a safe and effective measure for reducing the allergic reactions. This involves the consumption of small quantity of eggs daily in increasing amounts until a full serving is reached. People who suffer from major reactions due to an egg allergy carry medications like an emergency epinephrine injector to inject this into the blood stream anytime when the body has had a reaction due to the consumption of egg.
The hospitals & clinics segment held substantial market share in 2020
Based on end-users, the market can be segmented into hospitals & clinic, research institutes, diagnostic centers, and others. The hospitals & clinics segment held substantial market share in 2020. The rising awareness of healthcare centers and availability of medical service at hospitals have driven the hospitals and clinics segment. The rising number of skilled doctors and medical staff in hospitals that provide efficient and accurate diagnosis and treatment has shifted preference towards this segment.
North America dominates the global market
In terms of regions, the global egg allergy market can be split into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America constituted a significant share of the market in 2020 due to rising prevalence of egg allergies in the region. Moreover, increasing R&D spending by medical and pharmaceutical companies and growing healthcare infrastructure in the US are driving the market. The market in Asia Pacific is projected to expand at a significant CAGR during the forecast period due to growing R&D expenditure and government initiatives in the healthcare industry.

Segments
By Age Groups
By Diagnosis
- Skin Test
- Blood Test
- Food Challenge
- Others
By Treatments
- Medication
- Oral Immunotherapy
By End-users
- Hospitals & Clinics
- Diagnostic Centers
- Research Institutes
- Others
By Regions
- North America
- Europe
- Latin America
- Asia Pacific
- Middle East & Africa
By Key Players
- Genentech Inc.
- Novartis AG
- Pfizer Inc.
- Sun Pharmaceutical Industries Ltd.
- Bayer AG
- Abbott
- Astellas Pharma Inc.
- Sanofi
- Merck & Co. Inc.
- Creative Diagnostic Medicare Pvt. Ltd.
Competitive Landscape
Key players of the global egg allergy market include Genentech Inc.; Novartis AG.; Pfizer Inc.; Sun Pharmaceutical Industries Ltd.; Bayer AG; Abbott; Astellas Pharma Inc.; Sanofi; Merck & Co. Inc.; and Creative Diagnostic Medicare Pvt. Ltd. These players engage in mergers & acquisitions, collaborations, agreements, and partnerships to strengthen their geographical presence.

Table Of Content
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Egg Allergy Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Egg Allergy Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Egg Allergy Market - Supply Chain
4.5. Global Egg Allergy Market Forecast
4.5.1. Egg Allergy Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Egg Allergy Market Size (000’ Units) and Y-o-Y Growth
4.5.3. Egg Allergy Market Absolute $ Opportunity
5. Global Egg Allergy Market Analysis and Forecast by End Users
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by End Users
5.2.2. Y-o-Y Growth Projections by End Users
5.3. Egg Allergy Market Size and Volume Forecast by End Users
5.3.1. Hospitals & Clinics
5.3.2.
Diagnostic Centers
5.3.3.
Research Institutes
5.3.4.
Others
5.4. Absolute $ Opportunity Assessment by End Users
5.5. Market Attractiveness/Growth Potential Analysis by End Users
6. Global Egg Allergy Market Analysis and Forecast by Region
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Region
6.2.2. Y-o-Y Growth Projections by Region
6.3. Egg Allergy Market Size and Volume Forecast by Region
6.3.1. North America
6.3.2. Latin America
6.3.3. Europe
6.3.4. Asia Pacific
6.3.5. Middle East and Africa (MEA)
6.4. Absolute $ Opportunity Assessment by Region
6.5. Market Attractiveness/Growth Potential Analysis by Region
6.6. Global Egg Allergy Demand Share Forecast, 2019-2026
7. North America Egg Allergy Market Analysis and Forecast
7.1. Introduction
7.1.1. Basis Point Share (BPS) Analysis by Country
7.1.2. Y-o-Y Growth Projections by Country
7.2. North America Egg Allergy Market Size and Volume Forecast by Country
7.2.1. U.S.
7.2.2. Canada
7.3. Absolute $ Opportunity Assessment by Country
7.4. North America Egg Allergy Market Size and Volume Forecast by End Users
7.4.1. Hospitals & Clinics
7.4.2.
Diagnostic Centers
7.4.3.
Research Institutes
7.4.4.
Others
7.5. Basis Point Share (BPS) Analysis by End Users
7.6. Y-o-Y Growth Projections by End Users
7.7. Market Attractiveness/Growth Potential Analysis
7.7.1. By Country
7.7.2. By Product Type
7.7.3. By Application
7.8. North America Egg Allergy Demand Share Forecast, 2019-2026
8. Latin America Egg Allergy Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.1.3. Latin America Average Pricing Analysis
8.2. Latin America Egg Allergy Market Size and Volume Forecast by Country
8.2.1. Brazil
8.2.2. Mexico
8.2.3. Rest of Latin America
8.3. Absolute $ Opportunity Assessment by Country
8.4. Latin America Egg Allergy Market Size and Volume Forecast by End Users
8.4.1. Hospitals & Clinics
8.4.2.
Diagnostic Centers
8.4.3.
Research Institutes
8.4.4.
Others
8.5. Basis Point Share (BPS) Analysis by End Users
8.6. Y-o-Y Growth Projections by End Users
8.7. Market Attractiveness/Growth Potential Analysis
8.7.1. By Country
8.7.2. By Product Type
8.7.3. By Application
8.8. Latin America Egg Allergy Demand Share Forecast, 2019-2026
9. Europe Egg Allergy Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Europe Average Pricing Analysis
9.2. Europe Egg Allergy Market Size and Volume Forecast by Country
9.2.1. Germany
9.2.2. France
9.2.3. Italy
9.2.4. U.K.
9.2.5. Spain
9.2.6. Russia
9.2.7. Rest of Europe
9.3. Absolute $ Opportunity Assessment by Country
9.4. Europe Egg Allergy Market Size and Volume Forecast by End Users
9.4.1. Hospitals & Clinics
9.4.2.
Diagnostic Centers
9.4.3.
Research Institutes
9.4.4.
Others
9.5. Basis Point Share (BPS) Analysis by End Users
9.6. Y-o-Y Growth Projections by End Users
9.7. Market Attractiveness/Growth Potential Analysis
9.7.1. By Country
9.7.2. By Product Type
9.7.3. By Application
9.8. Europe Egg Allergy Demand Share Forecast, 2019-2026
10. Asia Pacific Egg Allergy Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Asia Pacific Average Pricing Analysis
10.2. Asia Pacific Egg Allergy Market Size and Volume Forecast by Country
10.2.1. China
10.2.2. Japan
10.2.3. South Korea
10.2.4. India
10.2.5. Australia
10.2.6. Rest of Asia Pacific (APAC)
10.3. Absolute $ Opportunity Assessment by Country
10.4. Asia Pacific Egg Allergy Market Size and Volume Forecast by End Users
10.4.1. Hospitals & Clinics
10.4.2.
Diagnostic Centers
10.4.3.
Research Institutes
10.4.4.
Others
10.5. Basis Point Share (BPS) Analysis by End Users
10.6. Y-o-Y Growth Projections by End Users
10.7. Market Attractiveness/Growth Potential Analysis
10.7.1. By Country
10.7.2. By Product Type
10.7.3. By Application
10.8. Asia Pacific Egg Allergy Demand Share Forecast, 2019-2026
11. Middle East & Africa Egg Allergy Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Middle East & Africa Average Pricing Analysis
11.2. Middle East & Africa Egg Allergy Market Size and Volume Forecast by Country
11.2.1. Saudi Arabia
11.2.2. South Africa
11.2.3. UAE
11.2.4. Rest of Middle East & Africa (MEA)
11.3. Absolute $ Opportunity Assessment by Country
11.4. Middle East & Africa Egg Allergy Market Size and Volume Forecast by End Users
11.4.1. Hospitals & Clinics
11.4.2.
Diagnostic Centers
11.4.3.
Research Institutes
11.4.4.
Others
11.5. Basis Point Share (BPS) Analysis by End Users
11.6. Y-o-Y Growth Projections by End Users
11.7. Market Attractiveness/Growth Potential Analysis
11.7.1. By Country
11.7.2. By Product Type
11.7.3. By Application
11.8. Middle East & Africa Egg Allergy Demand Share Forecast, 2019-2026
12. Competition Landscape
12.1. Global Egg Allergy Market: Market Share Analysis
12.2. Egg Allergy Distributors and Customers
12.3. Egg Allergy Market: Competitive Dashboard
12.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
12.4.1. Genentech Inc.
12.4.2.
Novartis AG.
12.4.3.
Pfizer Inc.
12.4.4.
Sun Pharmaceutical Industries Ltd.
12.4.5.
Bayer AG
12.4.6.
Abbott
12.4.7.
Astellas Pharma Inc.
12.4.8.
Sanofi&a